DESOGESTREL AND ETHINYL ESTRADIOL

DESOGESTREL AND ETHINYL ESTRADIOL was reported 3278 times

DESOGESTREL AND ETHINYL ESTRADIOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTRADUCTAL PAPILLARY BREAST NEOPLASM 2 0.1667
1 ABORTION SPONTANEOUS COMPLICATED 1 0.1250
2 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 10 0.0952
3 MUSCLE INJURY 775 0.0934
4 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 594 0.0914
5 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 51 0.0909
6 DUODENAL ULCER PERFORATION 663 0.0891
7 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 630 0.0878
8 DEEP VEIN THROMBOSIS POSTOPERATIVE 174 0.0869
9 C-REACTIVE PROTEIN 78 0.0841
10 FOLLICULITIS 824 0.0785
11 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 152 0.0733
12 SWOLLEN JOINT COUNT 18 0.0720
13 X-RAY ABNORMAL 127 0.0709
14 HELICOBACTER INFECTION 667 0.0648
15 RHEUMATIC FEVER 284 0.0636
16 TENDER JOINT COUNT 5 0.0595
17 FACET JOINT SYNDROME 189 0.0580
18 DISLOCATION OF VERTEBRA 132 0.0578
19 GRIP STRENGTH 13 0.0568
20 PEMPHIGUS 683 0.0546
21 SWOLLEN JOINT COUNT INCREASED 173 0.0542
22 C-REACTIVE PROTEIN ABNORMAL 326 0.0508
23 HAND DEFORMITY 643 0.0490
24 LUPUS VULGARIS 60 0.0476
25 ANDROGENS INCREASED 1 0.0435
26 ACQUIRED PORPHYRIA 3 0.0423
27 RHEUMATOID FACTOR POSITIVE 241 0.0417
28 PERIPHERAL VENOUS DISEASE 170 0.0416
29 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 27 0.0404
30 PERICARDITIS 675 0.0401
31 OVERLAP SYNDROME 27 0.0386
32 SYNOVITIS 677 0.0375
33 IRRITABLE BOWEL SYNDROME 773 0.0360
34 ABORTION INDUCED COMPLETE 1 0.0345
35 BREAST PROSTHESIS USER 2 0.0323
36 GLOSSODYNIA 645 0.0288
37 CRANIECTOMY 2 0.0274
38 RETINITIS 46 0.0266
39 LIP DRY 226 0.0249
40 IMPAIRED HEALING 792 0.0241
41 PORPHYRIA ACUTE 34 0.0237
42 BREAST CANCER STAGE III 152 0.0234
43 ACUTE MACULAR NEURORETINOPATHY 4 0.0234
44 ONYCHOMADESIS 98 0.0233
45 DISABILITY ASSESSMENT SCALE SCORE INCREASED 7 0.0228
46 WOUND 626 0.0224
47 ONYCHOMYCOSIS 92 0.0209
48 GRIP STRENGTH DECREASED 181 0.0205
49 LOWER RESPIRATORY TRACT INFECTION 929 0.0204
50 BURSITIS 247 0.0203
51 SYSTEMIC LUPUS ERYTHEMATOSUS 700 0.0197
52 JOINT RANGE OF MOTION DECREASED 262 0.0195
53 HEALTH ASSESSMENT QUESTIONNAIRE SCORE INCREASED 2 0.0192
54 SALPINGO-OOPHORECTOMY UNILATERAL 2 0.0182
55 MATERNAL EXPOSURE TIMING UNSPECIFIED 67 0.0178
56 AUTOIMMUNE DISORDER 168 0.0172
57 WOUND INFECTION 186 0.0170
58 SALPINGO-OOPHORECTOMY 2 0.0168
59 CONTRAINDICATED PRODUCT ADMINISTERED 496 0.0164
60 BONE EROSION 53 0.0150
61 PUSTULAR PSORIASIS 51 0.0148
62 LIVE BIRTH 123 0.0147
63 DEATH NEONATAL 20 0.0144
64 BLISTER 803 0.0143
65 THERAPEUTIC PRODUCT EFFECT DECREASED 631 0.0141
66 PELIOSIS HEPATIS 2 0.0139
67 STOMATITIS 815 0.0134
68 HEPATIC ENZYME 2 0.0134
69 FINGER DEFORMITY 65 0.0134
70 HYPERCHOLESTEROLAEMIA 128 0.0132
71 FIBROMYALGIA 315 0.0129
72 MUSCLE SPASTICITY 151 0.0123
73 ARTHROPATHY 660 0.0119
74 BREAST CANCER STAGE II 98 0.0118
75 OBESITY 182 0.0114
76 NIGHT SWEATS 350 0.0109
77 EAR PAIN 211 0.0108
78 INFUSION RELATED REACTION 710 0.0107
79 ILL-DEFINED DISORDER 650 0.0107
80 RASH VESICULAR 51 0.0105
81 PROTEIN S DEFICIENCY 2 0.0102
82 DISCOMFORT 619 0.0101
83 PRODUCT LABEL CONFUSION 58 0.0099
84 LIVER INJURY 242 0.0098
85 HEPATIC ENZYME INCREASED 669 0.0098
86 TYPE 2 DIABETES MELLITUS 330 0.0098
87 BLEPHAROSPASM 60 0.0095
88 COELIAC DISEASE 93 0.0095
89 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
90 SWELLING 855 0.0091
91 CONGENITAL ANOMALY 70 0.0090
92 NAIL DISORDER 79 0.0090
93 LOWER LIMB FRACTURE 170 0.0088
94 SERONEGATIVE ARTHRITIS 10 0.0087
95 GASTROINTESTINAL DISORDER 782 0.0087
96 GAIT INABILITY 281 0.0084
97 WALKING AID USER 55 0.0083
98 CARDIAC VALVE REPLACEMENT COMPLICATION 2 0.0082
99 PSORIATIC ARTHROPATHY 333 0.0082
100 DRUG TOLERANCE DECREASED 23 0.0082
101 SINUSITIS 830 0.0081
102 PREGNANCY ON ORAL CONTRACEPTIVE 21 0.0080
103 BUDD-CHIARI SYNDROME 2 0.0079
104 KERATOMILEUSIS 2 0.0078
105 SCIATICA 124 0.0078
106 PRESCRIBED OVERDOSE 150 0.0077
107 PREGNANCY TEST POSITIVE 3 0.0076
108 EPIGLOTTIC OEDEMA 2 0.0076
109 JOINT SWELLING 905 0.0075
110 BODY TEMPERATURE INCREASED 151 0.0074
111 PULMONARY FIBROSIS 141 0.0073
112 MILK ALLERGY 4 0.0072
113 BLOOD CHOLESTEROL INCREASED 327 0.0070
114 PREGNANCY 138 0.0069
115 AORTIC ATHEROSCLEROSIS 1 0.0068
116 OESTRADIOL INCREASED 2 0.0066
117 CONTUSION 624 0.0065
118 RESPIRATORY DISORDER 189 0.0063
119 FAECAL VOLUME DECREASED 3 0.0063
120 BACK INJURY 68 0.0062
121 DRUG INTOLERANCE 585 0.0060
122 EXOSTOSIS 54 0.0059
123 SLEEP DISORDER 412 0.0058
124 LEIOMYOMA 4 0.0058
125 URETERAL STENT INSERTION 2 0.0057
126 RHEUMATOID ARTHRITIS 647 0.0057
127 MYOSITIS 51 0.0057
128 HYPOCHOLESTEROLAEMIA 2 0.0057
129 PERIPHERAL SWELLING 873 0.0057
130 LUPUS-LIKE SYNDROME 51 0.0056
131 INTRACRANIAL VENOUS SINUS THROMBOSIS 6 0.0056
132 OSTEOARTHRITIS 234 0.0055
133 HIP ARTHROPLASTY 84 0.0055
134 ABNORMAL WITHDRAWAL BLEEDING 5 0.0054
135 MATERNAL EXPOSURE DURING PREGNANCY 471 0.0053
136 CONFUSIONAL STATE 851 0.0053
137 INFECTION 755 0.0052
138 GENERAL SYMPTOM 39 0.0052
139 ILEITIS 2 0.0052
140 ANTIPHOSPHOLIPID ANTIBODIES 1 0.0051
141 INJURY 352 0.0050
142 PRESCRIBED UNDERDOSE 94 0.0047
143 LOWER RESPIRATORY TRACT CONGESTION 8 0.0047
144 OVARIAN CYST RUPTURED 6 0.0047
145 ANGIOMYOLIPOMA 1 0.0047
146 DELIRIUM 160 0.0046
147 LUNG DISORDER 222 0.0045
148 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 77 0.0045
149 WHEEZING 265 0.0045
150 RED BLOOD CELL SEDIMENTATION RATE INCREASED 49 0.0044
151 NASOPHARYNGITIS 815 0.0044
152 OEDEMA 239 0.0044
153 SYNOVIAL DISORDER 2 0.0044
154 GALLBLADDER CHOLESTEROLOSIS 2 0.0044
155 VULVOVAGINAL INFLAMMATION 2 0.0043
156 MANUFACTURING ISSUE 2 0.0043
157 HYPERSENSITIVITY 795 0.0043
158 ROAD TRAFFIC ACCIDENT 177 0.0042
159 PROTEUS INFECTION 3 0.0042
160 CERVIX DISORDER 3 0.0042
161 MUSCULOSKELETAL PAIN 214 0.0041
162 ABDOMINAL DISCOMFORT 684 0.0041
163 INFUSION SITE REACTION 12 0.0040
164 MOBILITY DECREASED 288 0.0040
165 ACETONAEMIA 1 0.0040
166 C-REACTIVE PROTEIN INCREASED 141 0.0039
167 DRUG-INDUCED LIVER INJURY 121 0.0039
168 INFLAMMATION 196 0.0038
169 SUPERIOR SAGITTAL SINUS THROMBOSIS 3 0.0038
170 EPHELIDES 2 0.0037
171 WEIGHT INCREASED 830 0.0037
172 KNEE ARTHROPLASTY 78 0.0037
173 ULCER HAEMORRHAGE 25 0.0037
174 ALOPECIA 723 0.0037
175 NORMAL NEWBORN 20 0.0037
176 SCIATIC NERVE INJURY 3 0.0036
177 THERAPY NON-RESPONDER 161 0.0036
178 MUSCULOSKELETAL STIFFNESS 311 0.0035
179 GALLBLADDER NON-FUNCTIONING 2 0.0035
180 AGITATED DEPRESSION 1 0.0035
181 LIVER DISORDER 153 0.0034
182 BACK DISORDER 56 0.0034
183 MALIGNANT PERITONEAL NEOPLASM 2 0.0034
184 ADENOMYOSIS 2 0.0034
185 PULMONARY INFARCTION 8 0.0034
186 GENERAL PHYSICAL HEALTH DETERIORATION 389 0.0034
187 CEREBRAL VENOUS THROMBOSIS 6 0.0033
188 LIVER FUNCTION TEST INCREASED 69 0.0032
189 INTENTIONAL PRODUCT USE ISSUE 275 0.0031
190 TREATMENT FAILURE 260 0.0031
191 ANTIPHOSPHOLIPID SYNDROME 5 0.0031
192 URINARY SEDIMENT PRESENT 2 0.0031
193 DISABILITY 61 0.0031
194 DRY MOUTH 250 0.0031
195 ACANTHOSIS 1 0.0030
196 MESENTERIC VEIN THROMBOSIS 3 0.0030
197 PERITONEAL HAEMORRHAGE 4 0.0029
198 EPILEPSY 88 0.0029
199 URINE LEUKOCYTE ESTERASE POSITIVE 2 0.0029
200 ACQUIRED DIAPHRAGMATIC EVENTRATION 1 0.0028
201 URTICARIA 469 0.0028
202 FOOT DEFORMITY 31 0.0028
203 ADVERSE REACTION 37 0.0028
204 HEPATIC CIRRHOSIS 52 0.0028
205 MEDICATION ERROR 153 0.0027
206 WITHDRAWAL BLEED 2 0.0027
207 HEPATITIS 70 0.0027
208 CEREBRAL VASOCONSTRICTION 2 0.0027
209 CHOLECYSTITIS CHRONIC 18 0.0027
210 EYE INJURY 8 0.0026
211 GENITAL HERPES 4 0.0026
212 ERYTHEMA NODOSUM 9 0.0026
213 ABDOMINAL SYMPTOM 2 0.0025
214 SPONDYLITIS 9 0.0025
215 CHRONIC HEPATITIS 2 0.0025
216 ALLERGY TO CHEMICALS 3 0.0024
217 AMNESIA 153 0.0023
218 TASTE DISORDER 47 0.0023
219 ENDOMETRIOSIS 11 0.0023
220 ABSCESS DRAINAGE 2 0.0023
221 WISDOM TEETH REMOVAL 3 0.0023
222 JOINT DISLOCATION 24 0.0023
223 EXPOSURE DURING PREGNANCY 141 0.0023
224 PRURITUS 867 0.0023
225 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 2 0.0022
226 PYREXIA 761 0.0022
227 AGORAPHOBIA 3 0.0022
228 RASH 941 0.0022
229 ABDOMINAL PAIN UPPER 442 0.0021
230 OVARIAN DISORDER 2 0.0021
231 ARTHRALGIA 883 0.0021
232 CATAPLEXY 3 0.0021
233 ADVERSE EVENT 195 0.0021
234 GLUTEN SENSITIVITY 3 0.0021
235 WEIGHT FLUCTUATION 22 0.0021
236 PELVIC VENOUS THROMBOSIS 3 0.0021
237 MIGRAINE 199 0.0021
238 ARTERIOVENOUS FISTULA 1 0.0020
239 DYSPEPSIA 197 0.0020
240 CORONARY ARTERY THROMBOSIS 4 0.0020
241 URINARY TRACT INFECTION BACTERIAL 5 0.0020
242 SPINAL FUSION SURGERY 8 0.0020
243 UTERINE PAIN 2 0.0019
244 POLYCYSTIC OVARIES 3 0.0019
245 INFERTILITY FEMALE 3 0.0019
246 JOINT DESTRUCTION 3 0.0019
247 FREQUENT BOWEL MOVEMENTS 52 0.0019
248 HYPOAESTHESIA 288 0.0019
249 PRE-EXISTING CONDITION IMPROVED 12 0.0019
250 EAR INFECTION 51 0.0019
251 INFECTIOUS MONONUCLEOSIS 4 0.0018
252 TYMPANIC MEMBRANE PERFORATION 3 0.0018
253 BILIARY DYSKINESIA 3 0.0018
254 SEIZURE LIKE PHENOMENA 3 0.0018
255 CEREBRAL THROMBOSIS 5 0.0018
256 METRORRHAGIA 30 0.0018
257 VOMITING PROJECTILE 5 0.0017
258 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 1 0.0017
259 THROMBOPHLEBITIS 6 0.0017
260 JUGULAR VEIN THROMBOSIS 3 0.0017
261 JOINT ARTHROPLASTY 3 0.0017
262 ALLERGY TO METALS 1 0.0016
263 UTERINE SPASM 3 0.0016
264 HEPATIC PAIN 7 0.0016
265 INSOMNIA 432 0.0016
266 INJECTION SITE REACTION 111 0.0016
267 INTRADUCTAL PROLIFERATIVE BREAST LESION 2 0.0016
268 DYSPNOEA 895 0.0016
269 CONDITION AGGRAVATED 475 0.0016
270 PAIN 956 0.0016
271 ASTHMA 175 0.0015
272 MEMORY IMPAIRMENT 212 0.0015
273 GALLBLADDER INJURY 3 0.0015
274 ADJUSTMENT DISORDER 2 0.0015
275 JOINT STIFFNESS 40 0.0015
276 LARGE INTESTINAL STENOSIS 3 0.0015
277 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
278 BREAST SWELLING 4 0.0015
279 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
280 CHEST PAIN 273 0.0015
281 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 25 0.0015
282 SKIN DEPIGMENTATION 2 0.0015
283 HYPERTENSION 310 0.0015
284 ARACHNOIDITIS 1 0.0014
285 ANGULAR CHEILITIS 1 0.0014
286 INTRACRANIAL PRESSURE INCREASED 8 0.0014
287 INTERMENSTRUAL BLEEDING 8 0.0014
288 APPLICATION SITE ULCER 1 0.0014
289 PRODUCT USE ISSUE 265 0.0014
290 SMEAR CERVIX ABNORMAL 2 0.0014
291 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 100 0.0014
292 FACIAL PALSY 3 0.0014
293 ACCOMMODATION DISORDER 1 0.0014
294 PARAESTHESIA 215 0.0014
295 MUSCULAR WEAKNESS 155 0.0014
296 ELECTROCARDIOGRAM T WAVE INVERSION 3 0.0014
297 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 65 0.0014
298 AMINO ACID LEVEL INCREASED 1 0.0013
299 HYPERACUSIS 5 0.0013
300 NECK PAIN 75 0.0013
301 HYPOAESTHESIA FACIAL 2 0.0013
302 SUSPECTED OFF LABEL USE 6 0.0013
303 THROMBOPHLEBITIS SUPERFICIAL 4 0.0013
304 MENSTRUATION DELAYED 14 0.0013
305 GALLBLADDER DISORDER 23 0.0013
306 BACTERIAL VAGINOSIS 2 0.0013
307 LYMPHADENITIS 3 0.0012
308 ENURESIS 5 0.0012
309 DECREASED APPETITE 285 0.0012
310 ALLERGIC GRANULOMATOUS ANGIITIS 1 0.0012
311 FATIGUE 948 0.0012
312 ADVERSE DRUG REACTION 109 0.0012
313 ACCIDENTAL NEEDLE STICK 1 0.0012
314 DYSMENORRHOEA 16 0.0012
315 TROPONIN I INCREASED 2 0.0012
316 BREAST TENDERNESS 9 0.0012
317 COLITIS ISCHAEMIC 8 0.0012
318 MATERNAL EXPOSURE BEFORE PREGNANCY 8 0.0012
319 COLITIS ULCERATIVE 52 0.0012
320 JOINT EFFUSION 8 0.0012
321 FLUID RETENTION 59 0.0012
322 PUPIL FIXED 2 0.0012
323 POLYMENORRHOEA 4 0.0012
324 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
325 EXTREMITY NECROSIS 2 0.0011
326 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
327 OSTEOPOROSIS 47 0.0011
328 MENORRHAGIA 22 0.0011
329 MENSTRUATION IRREGULAR 30 0.0011
330 MUSCLE SPASMS 204 0.0011
331 CONTRAST MEDIA ALLERGY 2 0.0011
332 CHOLECYSTITIS 13 0.0011
333 VOMITING 509 0.0011
334 GASTROOESOPHAGEAL REFLUX DISEASE 87 0.0011
335 ADENOCARCINOMA GASTRIC 1 0.0011
336 ASTHENIA 403 0.0011
337 OEDEMA PERIPHERAL 130 0.0011
338 NARCOLEPSY 2 0.0011
339 HYPERCOAGULATION 2 0.0010
340 MENOMETRORRHAGIA 2 0.0010
341 APPLICATION SITE BRUISE 1 0.0010
342 RECTAL HAEMORRHAGE 44 0.0010
343 DEPRESSION 233 0.0010
344 MUCOUS STOOLS 5 0.0010
345 OVARIAN CYST 10 0.0010
346 FOAMING AT MOUTH 2 0.0010
347 PULMONARY EMBOLISM 94 0.0010
348 DRUG TOLERANCE 5 0.0010
349 VITAMIN B12 DEFICIENCY 4 0.0010
350 MEDICAL DEVICE DISCOMFORT 3 0.0010
351 DERMATITIS PSORIASIFORM 2 0.0010
352 ATRIAL THROMBOSIS 2 0.0010
353 FEELING HOT 59 0.0010
354 PRODUCT USE IN UNAPPROVED INDICATION 236 0.0010
355 ABDOMINAL DISTENSION 99 0.0009
356 UTERINE PERFORATION 8 0.0009
357 MEDICAL DEVICE PAIN 2 0.0009
358 GASTRIC CANCER STAGE IV 2 0.0009
359 OTITIS MEDIA 3 0.0009
360 LYME DISEASE 3 0.0009
361 BACTERIAL TEST POSITIVE 2 0.0009
362 BREAST MASS 6 0.0009
363 UNDERDOSE 65 0.0009
364 HEAVY MENSTRUAL BLEEDING 8 0.0009
365 GASTRIC POLYPS 2 0.0009
366 PREGNANCY AFTER POST COITAL CONTRACEPTION 2 0.0009
367 HEADACHE 555 0.0009
368 RENAL COLIC 2 0.0009
369 DYSPAREUNIA 4 0.0009
370 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 2 0.0009
371 APPLICATION SITE DISCHARGE 1 0.0009
372 REACTION TO EXCIPIENT 2 0.0009
373 TACHYPHRENIA 3 0.0009
374 ANXIETY 246 0.0009
375 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
376 OVARIAN HYPERSTIMULATION SYNDROME 2 0.0009
377 ALLODYNIA 1 0.0009
378 AMENORRHOEA 15 0.0009
379 INGROWING NAIL 2 0.0008
380 APPENDICECTOMY 3 0.0008
381 MYOPIA 2 0.0008
382 ABDOMINAL PAIN LOWER 21 0.0008
383 BACK PAIN 191 0.0008
384 PANCREATITIS 43 0.0008
385 UPPER RESPIRATORY TRACT INFECTION 37 0.0008
386 APPLICATION SITE SCAR 1 0.0008
387 AORTIC VALVE REPLACEMENT 1 0.0008
388 ABDOMINAL PAIN 183 0.0008
389 BLOOD PRESSURE DIASTOLIC ABNORMAL 2 0.0008
390 ADNEXA UTERI PAIN 1 0.0008
391 PANIC DISORDER 3 0.0008
392 DIARRHOEA 499 0.0008
393 GAIT DISTURBANCE 147 0.0008
394 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
395 APPENDICITIS 7 0.0007
396 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
397 STEATORRHOEA 2 0.0007
398 DEEP VEIN THROMBOSIS 48 0.0007
399 INCORRECT PRODUCT ADMINISTRATION DURATION 16 0.0007
400 CHOLELITHIASIS 24 0.0007
401 CROHN'S DISEASE 5 0.0007
402 HYPOMENORRHOEA 2 0.0007
403 TOOTH FRACTURE 8 0.0007
404 THYROID NEOPLASM 2 0.0007
405 TENOSYNOVITIS 2 0.0007
406 PLEURITIC PAIN 2 0.0007
407 HYPERTRANSAMINASAEMIA 5 0.0007
408 ANAL HAEMORRHAGE 2 0.0007
409 PAIN IN EXTREMITY 209 0.0007
410 UTERINE HAEMORRHAGE 3 0.0007
411 VITAMIN B12 DECREASED 2 0.0007
412 PRURITUS GENERALISED 15 0.0007
413 HYSTERECTOMY 6 0.0007
414 DIZZINESS 339 0.0007
415 MALAISE 298 0.0007
416 APRAXIA 1 0.0007
417 PLEURISY 4 0.0007
418 BRAIN HERNIATION 2 0.0007
419 URINE ANALYSIS ABNORMAL 2 0.0007
420 ACNE CYSTIC 2 0.0007
421 SUDDEN DEATH 7 0.0007
422 SCHIZOPHRENIA 8 0.0007
423 VULVOVAGINAL BURNING SENSATION 4 0.0007
424 ECTOPIC PREGNANCY 2 0.0006
425 LABORATORY TEST ABNORMAL 19 0.0006
426 PERFORMANCE STATUS DECREASED 3 0.0006
427 WEIGHT DECREASED 178 0.0006
428 DRUG INEFFECTIVE 834 0.0006
429 SUBCUTANEOUS ABSCESS 3 0.0006
430 WHITE BLOOD CELL COUNT INCREASED 24 0.0006
431 ENTERITIS 4 0.0006
432 VULVOVAGINAL PAIN 3 0.0006
433 PROCTALGIA 4 0.0006
434 VULVOVAGINAL DRYNESS 2 0.0006
435 PNEUMONIA 200 0.0006
436 PSORIASIS 80 0.0006
437 PRODUCT FORMULATION ISSUE 4 0.0006
438 PELVIC PAIN 11 0.0006
439 OLIGOHYDRAMNIOS 2 0.0006
440 TACHYCARDIA 53 0.0006
441 POTENTIATING DRUG INTERACTION 2 0.0006
442 VITAMIN D DECREASED 5 0.0006
443 TRISMUS 3 0.0006
444 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
445 FOETAL EXPOSURE DURING PREGNANCY 47 0.0006
446 VAGINAL HAEMORRHAGE 25 0.0006
447 CAROTID ARTERY STENOSIS 2 0.0006
448 SPINAL OSTEOARTHRITIS 5 0.0006
449 POLYARTHRITIS 3 0.0006
450 FACIAL PARESIS 2 0.0006
451 MACULOPATHY 2 0.0006
452 FOOD INTOLERANCE 2 0.0005
453 OFF LABEL USE 478 0.0005
454 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
455 FEELING DRUNK 4 0.0005
456 ABORTION INCOMPLETE 1 0.0005
457 PHOTOPHOBIA 10 0.0005
458 NAUSEA 417 0.0005
459 AFFECT LABILITY 5 0.0005
460 ARTERIAL THROMBOSIS 1 0.0005
461 INFLAMMATORY BOWEL DISEASE 5 0.0005
462 VENOUS THROMBOSIS 2 0.0005
463 DECREASED INTEREST 3 0.0005
464 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
465 LIGAMENT SPRAIN 5 0.0005
466 RESPIRATORY TRACT CONGESTION 8 0.0005
467 ANORECTAL DISORDER 1 0.0005
468 CANDIDIASIS 2 0.0005
469 HEPATITIS CHOLESTATIC 3 0.0005
470 INTRACRANIAL ANEURYSM 2 0.0005
471 ORGAN FAILURE 2 0.0005
472 BRONCHITIS 36 0.0005
473 MENSTRUAL DISORDER 4 0.0005
474 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
475 UNINTENDED PREGNANCY 5 0.0005
476 MOOD ALTERED 13 0.0005
477 BLOOD URINE PRESENT 9 0.0005
478 MUSCLE FATIGUE 2 0.0005
479 MUSCLE STRAIN 4 0.0005
480 ORAL HERPES 9 0.0005
481 HOSPITALISATION 69 0.0004
482 OCULAR DISCOMFORT 5 0.0004
483 ARTHRITIS 35 0.0004
484 PRODUCT TASTE ABNORMAL 6 0.0004
485 CHOLECYSTECTOMY 5 0.0004
486 INJECTION SITE PAPULE 2 0.0004
487 NERVE COMPRESSION 4 0.0004
488 EXTRASYSTOLES 3 0.0004
489 VISUAL IMPAIRMENT 53 0.0004
490 MANIA 7 0.0004
491 ABORTION SPONTANEOUS 17 0.0004
492 TREATMENT NONCOMPLIANCE 23 0.0004
493 MEDICATION RESIDUE PRESENT 2 0.0004
494 DERMATITIS BULLOUS 3 0.0004
495 HORMONE LEVEL ABNORMAL 2 0.0004
496 RESTLESSNESS 15 0.0004
497 PRODUCT QUALITY ISSUE 55 0.0004
498 INFLAMMATORY MARKER INCREASED 2 0.0004
499 ABDOMINAL TENDERNESS 2 0.0004
500 IMMUNODEFICIENCY 6 0.0004
501 ANEURYSM 2 0.0004
502 PANCREATITIS ACUTE 9 0.0004
503 OROPHARYNGEAL PAIN 37 0.0004
504 SECRETION DISCHARGE 5 0.0004
505 BRAIN OEDEMA 5 0.0004
506 THERAPEUTIC RESPONSE DECREASED 24 0.0004
507 VAGINAL DISCHARGE 4 0.0004
508 APPENDICITIS PERFORATED 1 0.0004
509 ANGLE CLOSURE GLAUCOMA 1 0.0004
510 ABDOMINAL INFECTION 1 0.0004
511 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
512 PHLEBITIS 2 0.0004
513 PRODUCT COLOUR ISSUE 2 0.0004
514 FOOD ALLERGY 3 0.0004
515 CEREBRAL ISCHAEMIA 2 0.0004
516 TENDONITIS 6 0.0004
517 SKIN NECROSIS 2 0.0004
518 MOOD SWINGS 12 0.0004
519 BREAST PAIN 4 0.0004
520 AREFLEXIA 1 0.0004
521 ALCOHOL POISONING 1 0.0004
522 HEREDITARY ANGIOEDEMA 4 0.0004
523 STRESS FRACTURE 2 0.0004
524 PHARYNGITIS STREPTOCOCCAL 4 0.0004
525 RASH PRURITIC 20 0.0004
526 BIPOLAR DISORDER 4 0.0004
527 HYPERAESTHESIA 3 0.0004
528 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
529 GASTROINTESTINAL PAIN 4 0.0004
530 EMBOLISM 3 0.0004
531 HUNGER 5 0.0004
532 SKIN INFECTION 4 0.0004
533 PERIORBITAL SWELLING 2 0.0004
534 CHOLECYSTITIS ACUTE 2 0.0004
535 PERONEAL NERVE PALSY 2 0.0004
536 GENERALISED ERYTHEMA 2 0.0004
537 VISUAL DISTURBANCE 2 0.0003
538 EXERCISE TOLERANCE DECREASED 2 0.0003
539 MOUTH SWELLING 2 0.0003
540 SKIN SWELLING 3 0.0003
541 HYPERVENTILATION 2 0.0003
542 METABOLIC DISORDER 2 0.0003
543 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
544 ECZEMA 18 0.0003
545 DERMATITIS ATOPIC 18 0.0003
546 DEPRESSED MOOD 18 0.0003
547 BLOOD IRON DECREASED 4 0.0003
548 CATARACT OPERATION 2 0.0003
549 HYPOAESTHESIA ORAL 5 0.0003
550 TOOTHACHE 6 0.0003
551 OVERDOSE 71 0.0003
552 HIDRADENITIS 3 0.0003
553 PIGMENTATION DISORDER 2 0.0003
554 DRUG EXPOSURE DURING PREGNANCY 11 0.0003
555 NASAL CONGESTION 19 0.0003
556 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 23 0.0003
557 INFUSION SITE EXTRAVASATION 2 0.0003
558 ABORTION INDUCED 3 0.0003
559 NIGHTMARE 11 0.0003
560 ABDOMINAL ADHESIONS 1 0.0003
561 HYPOTHYROIDISM 10 0.0003
562 RASH PAPULAR 7 0.0003
563 THROAT IRRITATION 14 0.0003
564 CARDIAC FLUTTER 2 0.0003
565 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
566 HEPATITIS ACUTE 2 0.0003
567 POLYP 2 0.0003
568 THERAPY CHANGE 3 0.0003
569 BODY TEMPERATURE DECREASED 3 0.0003
570 APPETITE DISORDER 2 0.0003
571 ANXIETY DISORDER 1 0.0003
572 PRODUCT LABEL ISSUE 2 0.0003
573 IMPAIRED GASTRIC EMPTYING 4 0.0003
574 DRUG ADMINISTRATION ERROR 9 0.0003
575 INITIAL INSOMNIA 3 0.0003
576 EAR DISCOMFORT 3 0.0003
577 INFARCTION 2 0.0003
578 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
579 HAIR GROWTH ABNORMAL 2 0.0003
580 PETECHIAE 3 0.0003
581 AORTIC STENOSIS 1 0.0003
582 CEREBRAL INFARCTION 7 0.0003
583 SKIN REACTION 4 0.0003
584 DECREASED ACTIVITY 3 0.0003
585 APPARENT DEATH 1 0.0003
586 COMPLICATION OF DEVICE REMOVAL 5 0.0003
587 HYPERTHYROIDISM 4 0.0003
588 PULMONARY THROMBOSIS 3 0.0003
589 UTERINE LEIOMYOMA 2 0.0003
590 THROMBOSIS 22 0.0003
591 INJECTION SITE NODULE 3 0.0003
592 BLINDNESS TRANSIENT 2 0.0003
593 AMYLASE INCREASED 1 0.0003
594 PSYCHOTIC DISORDER 8 0.0003
595 INJECTION SITE PRURITUS 18 0.0003
596 HEPATIC STEATOSIS 5 0.0003
597 HEART RATE IRREGULAR 6 0.0003
598 INTENTIONAL PRODUCT MISUSE 23 0.0003
599 MICTURITION URGENCY 3 0.0003
600 MULTIPLE SCLEROSIS RELAPSE 18 0.0003
601 GASTRIC DISORDER 9 0.0003
602 THROAT TIGHTNESS 7 0.0003
603 CONCUSSION 2 0.0003
604 CAESAREAN SECTION 3 0.0003
605 CHOKING 5 0.0003
606 FALL 85 0.0003
607 GASTROINTESTINAL INFLAMMATION 2 0.0003
608 KIDNEY INFECTION 5 0.0003
609 HAEMATOCHEZIA 14 0.0003
610 ATAXIA 3 0.0003
611 FURUNCLE 2 0.0003
612 NASAL DISCOMFORT 2 0.0003
613 LOW BIRTH WEIGHT BABY 2 0.0003
614 PRODUCTIVE COUGH 12 0.0003
615 GINGIVAL PAIN 2 0.0003
616 ARTERIOSPASM CORONARY 1 0.0002
617 ADRENAL INSUFFICIENCY 3 0.0002
618 APPLICATION SITE DISCOLOURATION 1 0.0002
619 SHOCK HAEMORRHAGIC 2 0.0002
620 INTENTIONAL DOSE OMISSION 7 0.0002
621 PRODUCT SUBSTITUTION ISSUE 14 0.0002
622 INJECTION SITE EXTRAVASATION 3 0.0002
623 INJECTION SITE WARMTH 5 0.0002
624 APPLICATION SITE EXFOLIATION 1 0.0002
625 HEART RATE INCREASED 24 0.0002
626 SKIN DISORDER 8 0.0002
627 NEPHROLITHIASIS 11 0.0002
628 DYSSTASIA 7 0.0002
629 PALPITATIONS 28 0.0002
630 ATRIAL SEPTAL DEFECT 2 0.0002
631 SKIN PLAQUE 2 0.0002
632 HEMIPARESIS 4 0.0002
633 AORTIC VALVE INCOMPETENCE 1 0.0002
634 DEVICE DEPLOYMENT ISSUE 3 0.0002
635 ABSCESS LIMB 1 0.0002
636 ANOREXIA 3 0.0002
637 PSYCHOLOGICAL TRAUMA 2 0.0002
638 HIATUS HERNIA 3 0.0002
639 MYOPATHY 2 0.0002
640 INJECTION SITE RASH 7 0.0002
641 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
642 ABDOMINAL ABSCESS 1 0.0002
643 UNEVALUABLE EVENT 17 0.0002
644 FACIAL PAIN 2 0.0002
645 THIRST 4 0.0002
646 FOREIGN BODY IN REPRODUCTIVE TRACT 2 0.0002
647 THROMBOCYTOPENIA 25 0.0002
648 LOSS OF LIBIDO 2 0.0002
649 DYSPHAGIA 21 0.0002
650 UVEITIS 3 0.0002
651 BLINDNESS 9 0.0002
652 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
653 OPTIC NEURITIS 2 0.0002
654 AGGRESSION 11 0.0002
655 PANIC ATTACK 8 0.0002
656 UROSEPSIS 2 0.0002
657 IRRITABILITY 13 0.0002
658 CONJUNCTIVITIS 4 0.0002
659 EYE SWELLING 8 0.0002
660 MASS 3 0.0002
661 ERYTHEMA MULTIFORME 2 0.0002
662 DEFORMITY 2 0.0002
663 DIARRHOEA HAEMORRHAGIC 2 0.0002
664 OXYGEN SATURATION DECREASED 12 0.0002
665 FLANK PAIN 2 0.0002
666 EYE DISORDER 7 0.0002
667 SEASONAL ALLERGY 3 0.0002
668 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
669 SLEEP APNOEA SYNDROME 4 0.0002
670 INCREASED APPETITE 4 0.0002
671 BLOOD PRESSURE FLUCTUATION 5 0.0002
672 DRUG INTERACTION 33 0.0002
673 SUICIDAL IDEATION 19 0.0002
674 ANGER 7 0.0002
675 SINUS BRADYCARDIA 2 0.0002
676 INJECTION SITE HAEMATOMA 3 0.0002
677 MENTAL IMPAIRMENT 5 0.0002
678 DIZZINESS POSTURAL 2 0.0002
679 APATHY 3 0.0002
680 PRESYNCOPE 5 0.0002
681 GASTROENTERITIS 3 0.0002
682 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
683 EMBEDDED DEVICE 2 0.0002
684 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
685 SWELLING FACE 13 0.0002
686 HEART RATE DECREASED 7 0.0002
687 URINARY TRACT INFECTION 34 0.0002
688 APHASIA 6 0.0002
689 ACNE 15 0.0002
690 SUBARACHNOID HAEMORRHAGE 2 0.0002
691 SLUGGISHNESS 2 0.0002
692 INJECTION SITE SWELLING 15 0.0002
693 CHEST DISCOMFORT 20 0.0002
694 PHARYNGEAL OEDEMA 3 0.0002
695 TEMPERATURE INTOLERANCE 2 0.0002
696 INJECTION SITE ERYTHEMA 24 0.0002
697 POOR VENOUS ACCESS 2 0.0002
698 CRYING 7 0.0002
699 PHARMACEUTICAL PRODUCT COMPLAINT 5 0.0002
700 DIPLOPIA 5 0.0002
701 RESPIRATORY TRACT INFECTION 5 0.0002
702 FEELING ABNORMAL 46 0.0002
703 POLLAKIURIA 8 0.0002
704 APLASTIC ANAEMIA 1 0.0002
705 ANHEDONIA 5 0.0002
706 GASTRITIS 5 0.0002
707 SCRATCH 2 0.0002
708 DYSPHONIA 11 0.0002
709 ANAL FISTULA 1 0.0002
710 IMPAIRED WORK ABILITY 4 0.0002
711 ANAL FISSURE 1 0.0002
712 FEAR 5 0.0002
713 POOR QUALITY SLEEP 4 0.0002
714 PAIN OF SKIN 5 0.0002
715 MENTAL DISORDER 8 0.0002
716 PRODUCT DOSE OMISSION 12 0.0002
717 PRODUCT DISPENSING ERROR 4 0.0002
718 VENTRICULAR TACHYCARDIA 3 0.0002
719 ABNORMAL DREAMS 5 0.0002
720 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
721 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
722 PROCEDURAL PAIN 5 0.0002
723 EYE INFECTION 2 0.0002
724 MYOCARDIAL ISCHAEMIA 2 0.0002
725 SCAR 3 0.0002
726 MUSCULOSKELETAL DISCOMFORT 3 0.0002
727 EYE IRRITATION 10 0.0002
728 HYPOKALAEMIA 8 0.0002
729 HOT FLUSH 13 0.0002
730 EYELID OEDEMA 2 0.0002
731 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 31 0.0002
732 LOCAL SWELLING 3 0.0002
733 VASCULITIS 2 0.0002
734 COGNITIVE DISORDER 8 0.0002
735 SPINAL PAIN 2 0.0002
736 DRUG DOSE OMISSION 28 0.0002
737 ISCHAEMIC STROKE 3 0.0002
738 MYOCLONUS 2 0.0002
739 CEREBRAL HAEMORRHAGE 6 0.0002
740 DISTURBANCE IN ATTENTION 9 0.0002
741 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
742 GASTROENTERITIS VIRAL 3 0.0002
743 NO ADVERSE EVENT 30 0.0002
744 SEIZURE 19 0.0002
745 DYSURIA 6 0.0002
746 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
747 PHARYNGITIS 2 0.0002
748 CYST 2 0.0002
749 BACTERIAL INFECTION 3 0.0002
750 MIDDLE INSOMNIA 3 0.0002
751 DRY EYE 8 0.0002
752 INJECTION SITE DISCOLOURATION 2 0.0002
753 LEUKOPENIA 8 0.0002
754 INJECTION SITE PAIN 49 0.0002
755 HALLUCINATION 12 0.0002
756 DERMATITIS ALLERGIC 2 0.0002
757 PRODUCT COMPLAINT 4 0.0002
758 GASTRIC ULCER 3 0.0002
759 FEELING JITTERY 3 0.0002
760 DRY SKIN 21 0.0002
761 EMOTIONAL DISTRESS 19 0.0002
762 INTRAOCULAR PRESSURE INCREASED 2 0.0002
763 LETHARGY 9 0.0002
764 SEROTONIN SYNDROME 3 0.0002
765 ILLNESS 16 0.0002
766 RASH GENERALISED 4 0.0002
767 INJECTION SITE INDURATION 2 0.0002
768 APPLICATION SITE VESICLES 1 0.0002
769 SOMNOLENCE 31 0.0002
770 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
771 SURGERY 9 0.0002
772 PLATELET COUNT INCREASED 2 0.0002
773 SPEECH DISORDER 8 0.0002
774 IMMUNE SYSTEM DISORDER 2 0.0002
775 INJECTION SITE HAEMORRHAGE 12 0.0002
776 MALIGNANT MELANOMA 2 0.0001
777 QUALITY OF LIFE DECREASED 2 0.0001
778 PRODUCT PHYSICAL ISSUE 3 0.0001
779 INTENTIONAL SELF-INJURY 3 0.0001
780 PALLOR 4 0.0001
781 GINGIVAL BLEEDING 2 0.0001
782 RASH ERYTHEMATOUS 7 0.0001
783 VISION BLURRED 20 0.0001
784 PERIPHERAL COLDNESS 2 0.0001
785 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
786 BLOOD PRESSURE INCREASED 22 0.0001
787 HAEMOPTYSIS 4 0.0001
788 COORDINATION ABNORMAL 2 0.0001
789 DERMATITIS 3 0.0001
790 MOUTH ULCERATION 3 0.0001
791 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
792 APPLICATION SITE REACTION 1 0.0001
793 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
794 ERYTHEMA 29 0.0001
795 RETCHING 3 0.0001
796 JOINT INJURY 3 0.0001
797 CONVULSION 8 0.0001
798 HYPERHIDROSIS 18 0.0001
799 HYPERSOMNIA 4 0.0001
800 RHINORRHOEA 9 0.0001
801 PARAESTHESIA ORAL 2 0.0001
802 DEVICE DISLOCATION 6 0.0001
803 LIVER FUNCTION TEST ABNORMAL 4 0.0001
804 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
805 COVID-19 24 0.0001
806 PRODUCT DOSE OMISSION ISSUE 40 0.0001
807 COUGH 38 0.0001
808 INJECTION SITE MASS 5 0.0001
809 SKIN HAEMORRHAGE 2 0.0001
810 NERVOUSNESS 7 0.0001
811 HAEMORRHAGE 14 0.0001
812 DEVICE ISSUE 12 0.0001
813 HAEMORRHAGE INTRACRANIAL 2 0.0001
814 INFLUENZA LIKE ILLNESS 11 0.0001
815 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
816 ACIDOSIS 1 0.0001
817 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
818 MUSCLE TWITCHING 3 0.0001
819 THYROID DISORDER 2 0.0001
820 EMOTIONAL DISORDER 4 0.0001
821 ANKLE FRACTURE 2 0.0001
822 APHTHOUS ULCER 1 0.0001
823 BASAL CELL CARCINOMA 2 0.0001
824 SWOLLEN TONGUE 4 0.0001
825 AFFECTIVE DISORDER 1 0.0001
826 CYANOSIS 2 0.0001
827 SKIN BURNING SENSATION 9 0.0001
828 INFLUENZA 14 0.0001
829 LOSS OF CONSCIOUSNESS 16 0.0001
830 HYPOTENSION 25 0.0001
831 SENSORY DISTURBANCE 2 0.0001
832 MUSCLE TIGHTNESS 2 0.0001
833 BLOOD POTASSIUM INCREASED 2 0.0001
834 INJECTION SITE URTICARIA 3 0.0001
835 ACUTE CORONARY SYNDROME 1 0.0001
836 BLOOD PRESSURE DECREASED 8 0.0001
837 LIP SWELLING 4 0.0001
838 BONE PAIN 7 0.0001
839 CHILLS 14 0.0001
840 CONSTIPATION 26 0.0001
841 WITHDRAWAL SYNDROME 5 0.0001
842 EYE PRURITUS 4 0.0001
843 HAEMATEMESIS 3 0.0001
844 CARDIOVASCULAR DISORDER 3 0.0001
845 FLUSHING 12 0.0001
846 CIRCULATORY COLLAPSE 2 0.0001
847 HYPOPHAGIA 3 0.0001
848 ANAPHYLACTIC SHOCK 3 0.0001
849 ANURIA 1 0.0001
850 SKIN ULCER 3 0.0001
851 APPLICATION SITE ERYTHEMA 3 0.0001
852 RASH MACULAR 4 0.0001
853 COLD SWEAT 2 0.0001
854 LYMPHOCYTE COUNT DECREASED 2 0.0001
855 LYMPHADENOPATHY 4 0.0001
856 DRUG ERUPTION 2 0.0001
857 MYALGIA 19 0.0001
858 RESTLESS LEGS SYNDROME 2 0.0001
859 BONE DISORDER 2 0.0001
860 SKIN IRRITATION 5 0.0001
861 ANAPHYLACTIC REACTION 6 0.0001
862 TREMOR 18 0.0001
863 FEELING COLD 3 0.0001
864 THINKING ABNORMAL 2 0.0001
865 HAEMOGLOBIN DECREASED 11 0.0001
866 SKIN EXFOLIATION 9 0.0001
867 INTESTINAL OBSTRUCTION 4 0.0001
868 PAIN IN JAW 3 0.0001
869 FRACTURE 2 0.0001
870 OCULAR HYPERAEMIA 5 0.0001
871 MUSCULOSKELETAL DISORDER 2 0.0001
872 HERPES ZOSTER 6 0.0001
873 GLAUCOMA 2 0.0001
874 NEEDLE ISSUE 3 0.0001
875 SKIN FISSURES 2 0.0001
876 COMPLICATION OF DEVICE INSERTION 2 0.0001
877 SYNCOPE 10 0.0001
878 BURNING SENSATION 7 0.0001
879 BLOOD POTASSIUM DECREASED 3 0.0001
880 PREMATURE BABY 3 0.0001
881 PRODUCT ADMINISTRATION ERROR 2 0.0001
882 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
883 FEEDING DISORDER 2 0.0001
884 DEVICE BREAKAGE 4 0.0001
885 VERTIGO 6 0.0001
886 PRODUCT PREPARATION ERROR 2 0.0001
887 RIB FRACTURE 2 0.0001
888 LIMB DISCOMFORT 3 0.0001
889 INCORRECT DOSE ADMINISTERED 22 0.0001
890 PULMONARY HYPERTENSION 2 0.0001
891 HEAD INJURY 3 0.0001
892 EATING DISORDER 2 0.0001
893 MOVEMENT DISORDER 3 0.0001
894 FAECES DISCOLOURED 2 0.0001
895 DIABETES MELLITUS 7 0.0001
896 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
897 STAPHYLOCOCCAL INFECTION 3 0.0001
898 APPLICATION SITE PAIN 2 0.0001
899 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
900 VIRAL INFECTION 3 0.0001
901 HEPATOTOXICITY 2 0.0001
902 SNEEZING 2 0.0001
903 CHROMATURIA 2 0.0001
904 PRODUCT AVAILABILITY ISSUE 2 0.0001
905 INJECTION SITE BRUISING 7 0.0001
906 SKIN DISCOLOURATION 4 0.0001
907 SHOCK 2 0.0001
908 PERICARDIAL EFFUSION 2 0.0001
909 CARDIAC ARREST 7 0.0001
910 DISEASE RECURRENCE 4 0.0001
911 PRODUCT PRESCRIBING ERROR 2 0.0001
912 MULTIPLE SCLEROSIS 4 0.0001
913 CEREBROVASCULAR ACCIDENT 14 0.0001
914 DRUG EFFECT INCOMPLETE 3 0.0001
915 NEURALGIA 2 0.0001
916 ACCIDENTAL OVERDOSE 3 0.0001
917 ABASIA 2 0.0001
918 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
919 APPLICATION SITE IRRITATION 1 0.0001
920 DYSARTHRIA 3 0.0001
921 DYSPNOEA EXERTIONAL 3 0.0001
922 CELLULITIS 4 0.0001
923 ANKYLOSING SPONDYLITIS 1 0.0001
924 ABNORMAL BEHAVIOUR 3 0.0001
925 BRADYCARDIA 4 0.0001
926 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
927 ANAEMIA 14 0.0001
928 SKIN LESION 2 0.0001
929 RESPIRATORY ARREST 2 0.0001
930 APHONIA 1 0.0001
931 THERAPY INTERRUPTED 5 0.0001
932 ANGINA PECTORIS 2 0.0001
933 ACCIDENTAL UNDERDOSE 1 0.0001
934 ANOSMIA 1 0.0001
935 ACUTE MYOCARDIAL INFARCTION 2 0.0001
936 ANGIOEDEMA 3 0.0001
937 DEHYDRATION 9 0.0001
938 DYSGEUSIA 5 0.0001
939 EPISTAXIS 5 0.0001
940 SUICIDE ATTEMPT 4 0.0001
941 PLATELET COUNT DECREASED 7 0.0001
942 ARRHYTHMIA 3 0.0001
943 NEUROPATHY PERIPHERAL 6 0.0001
944 COMA 3 0.0001
945 CYSTITIS 2 0.0001
946 ABSCESS 1 0.0001
947 HYPOGLYCAEMIA 3 0.0001
948 VISUAL ACUITY REDUCED 2 0.0001
949 EXPIRED PRODUCT ADMINISTERED 2 0.0001
950 FUNGAL INFECTION 2 0.0001
951 URINARY RETENTION 2 0.0001
952 HAEMATURIA 2 0.0001
953 DEATH 50 0.0001
954 DRUG WITHDRAWAL SYNDROME 5 0.0001
955 DEVICE MALFUNCTION 4 0.0001
956 HYPOXIA 2 0.0001
957 PRODUCT ADHESION ISSUE 2 0.0001
958 DRUG EFFECT DECREASED 3 0.0001
959 HYPERGLYCAEMIA 2 0.0001
960 AGRANULOCYTOSIS 1 0.0001
961 EYE PAIN 3 0.0001
962 FLATULENCE 3 0.0001
963 COLITIS 2 0.0001
964 ACUTE RESPIRATORY FAILURE 1 0.0001
965 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
966 CARDIO-RESPIRATORY ARREST 2 0.0000
967 RENAL FAILURE ACUTE 2 0.0000
968 HYPOACUSIS 2 0.0000
969 ACUTE KIDNEY INJURY 7 0.0000
970 PRODUCT STORAGE ERROR 4 0.0000
971 PULMONARY OEDEMA 2 0.0000
972 TINNITUS 2 0.0000
973 CARDIAC DISORDER 4 0.0000
974 BLOOD GLUCOSE DECREASED 2 0.0000
975 INTERSTITIAL LUNG DISEASE 2 0.0000
976 ATRIAL FIBRILLATION 4 0.0000
977 AGITATION 3 0.0000
978 CHRONIC KIDNEY DISEASE 3 0.0000
979 RENAL FAILURE 5 0.0000
980 CARDIAC FAILURE CONGESTIVE 3 0.0000
981 DEPENDENCE 2 0.0000
982 SEPSIS 4 0.0000
983 RENAL IMPAIRMENT 3 0.0000
984 PLEURAL EFFUSION 2 0.0000
985 DEVICE EXPULSION 2 0.0000
986 BLOOD CREATININE INCREASED 2 0.0000
987 DISEASE PROGRESSION 3 0.0000
988 COMPLETED SUICIDE 2 0.0000
989 BLOOD GLUCOSE INCREASED 4 0.0000
990 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
991 NEUTROPENIA 2 0.0000
992 TOXICITY TO VARIOUS AGENTS 2 0.0000